Cytox Launches Genetic Test for Alzheimer’s Disease

July 22, 2016

Cytox has launched Variatech, a diagnostic test for Alzheimer’s Disease that relies on genetic biomarkers.

The blood-based test provides a comprehensive panel of AD informative SNPs to assist research and novel drug discovery studies.  

Company studies indicate it has an accuracy rate over 80 percent. — Cynthia Jessup

View today's stories